CliniNote closes seed financing round led by Sunfish Partners

PRESS RELEASE

CliniNote: Pioneering a Paradigm Shift in Healthcare Data

CliniNote, a Poland-based startup, is embarking on a transformative journey within the healthcare data industry. Created by a robust team of industry veterans and with its first institutional investment, CliniNote is poised to reshape how healthcare professionals work with clinical data.

CliniNote is addressing the challenges associated with collecting and processing clinical data, as crucial step for the seamless integration of Artificial Intelligence (AI) and Natural Language Processing (NLP) into healthcare workflows. This forward-looking approach involves transforming established practices and elevating efficiency to new heights.

The CliniNote Assistant empowers medical personnel by simplifying clinical documentation processes while effortlessly capturing comprehensive real-world  data via a software plugin. This innovative approach enhances the efficiency of medical documentation preparation and enables the creation of a database of Real-World Data, previously considered unattainable, without placing additional burdens on doctors, altering existing processes, or requiring a dedicated integration with hospital information systems.

CliniNote's technology extends beyond clinical documentation, offering increased efficiency in various data processes within healthcare and pharmaceutical domains like the acceleration of clinical trials, a critical process.

"It’s our mission to resolve the enduring dilemma of balancing the need to save doctors' time with the imperative to collect more clinical data, which is crucial for the transformation of the healthcare industry. We firmly believe that our solution also effectively addresses the pressing issue of interoperability in the healthcare industry" Robert Lugowski, CEO of CliniNote, commented.

CliniNote has successfully closed tit’s initial financing round, led by CEE focused early stage VC Sunfish Partners with additional support from business angels including Katarzyna Pieniądz, Pawel Mańdok, Pawel Woźniak, Piotr Ruciński and Winicjusz Filipow among others. CliniNote remains open to further investment opportunities and is gearing up to conclude the second part of the round in November. “We decided to back CliniNote as we believe in the enormous opportunity in this area ahead of the introduction of the European Health Data Space. Making unstructured treatment data usable for data exchange and applications in artificial intelligence is one of the most pressing challenges in digital healthcare. In CliniNote we found an extraordinary team with a bold vision and first implementations and partnerships tackling this very problem.” says Max Moldenhauer, Managing Partner of Sunfish Partners.

CliniNote remains open to further investment opportunities and is gearing up to conclude the second part of the round in Q4 2023.

For media inquiries and investment opportunities, please contact: press@clininote.com

About CliniNote:

CliniNote is a health-tech startup headquartered in Warsaw, Poland. It specializes in clinical AI and NLP solutions. It’s flagship product, the CliniNote Assistant, is revolutionizing how healthcare professionals interact with clinical data. Their innovative technology empowers doctors and medical staff to effortlessly collect vital clinical data without disrupting existing healthcare processes. CliniNote was founded in 2020 and currently employs 12 people.

About Sunfish Partners:

Sunfish Partners is an early-stage venture capital fund investing in outstanding tech-forward companies in Central and Eastern Europe. Sunfish has invested in 14 companies so far, including some of the most innovative companies in digital health in CEE like Molecule.one, Aether Biomedical, and Solvemed.ai. Sunfish Partners in based in Berlin and Warsaw and is managed by Dr. Marcus Erken, Max Moldenhauer, and Pawel Lipkowski.

Other news:

1 2 3

Let's dive into CliniNote and real-world data in healthcare

Get CliniNote